ADVM
NASDAQ
US
Adverum Biotechnologies, Inc. - Common Stock
$4.36
+0.08 (+1.9%)
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$96.3M
ROE
-91.0%
Margin
-3235.1%
D/E
0.00
Beta
0.93
52W
$2–$6
Wall Street Consensus
12 analysts · Apr 20262
Strong Buy
6
Buy
4
Hold
0
Sell
0
Strong Sell
66.7%
Buy Rating
Price Chart
Similar Stocks
CRDF
Cardiff Oncology Inc
$189.3M
CADL
Candel Therapeutics Inc
$310.2M
ALDX
Aldeyra Therapeutics Inc
$99.9M
SPRB
Spruce Biosciences, Inc
$93.2M
COYA
Coya Therapeutics Inc
$121.4M
QTTB
Q32 Bio Inc
$40.9M
PYXS
Pyxis Oncology Inc
$71.6M
RCEL
AVITA Medical Inc
$105.2M
MCRB
Seres Therapeutics Inc
P/E 25.0
$134.6M
GOSS
Gossamer Bio Inc
$717.5M
Earnings
Beat rate: 0.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Sep 2025 | $-1.61 | $-2.03 | $-0.42 |
| Jun 2025 | $-2.29 | $-2.34 | $-0.05 |
| Mar 2025 | $-1.85 | $-2.25 | $-0.40 |
| Dec 2024 | $-1.39 | $-1.96 | $-0.57 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | -91.0% | -91.0% | -91.0% | -91.0% | -91.0% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | -3235.1% | -3235.1% | -3235.1% | -3235.1% | -3235.1% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 1.54 | 3.57 | 1.54 | 1.54 | 1.54 | 0.65 |
Key Ratios
ROA (TTM)
-70.2%
P/S (TTM)
96.26
P/B
1.4
EPS (TTM)
$-3.99
CF/Share
$-1.19
Rev Growth 3Y
-48.9%
52W High
$5.75
52W Low
$1.78
$1.78
52-Week Range
$5.75
How does ADVM compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
ADVM valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
96.3
▲
649%
above
peers
(12.9)
vs Peers
vs Industry
Pricier
P/B ratio
1.4
▼
44%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
ADVM profitability vs Biotechnology peers
ROE
-91.0%
▼
35%
below
peers
(-67.3%)
vs Peers
vs Industry
Weak
Net margin
-3235.1%
▼
1028%
below
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-70.2%
▼
50%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
ADVM financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
0.7
▼
85%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
0.9
▼
4%
below
peers
(1.0)
vs Peers
vs Industry
Less volatile
ADVM fundamentals radar
ADVM
Peer median
Industry
ADVM profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
ADVM vs peers: key metrics
Latest News
No related news yet